Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
5-bromo-N-(4,4,5,5-tetradeuterio-1H-imidazol-2-yl)quinoxalin-6-amine;(2S,3S)-2,3-dihydroxybutanedioic acid
Application Notes
Useful research chemical for a range of applications
Hazard Compound
No -Refer MSDS for accurate information
Brimonidine-d4 D-Tartrate is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Brimonidine-d4 D-Tartrate usage and description
Brimonidine-d4 D-Tartrate is a medication that is used to treat glaucoma and ocular hypertension. It is a selective alpha-2 adrenergic receptor agonist that reduces intraocular pressure by decreasing the production of aqueous humor and increasing the outflow of aqueous humor. Brimonidine-d4 D-Tartrate is available in the form of eye drops and is administered directly to the affected eye.
The chemical formula of Brimonidine-d4 D-Tartrate is C11H10D4BrN5.C4H6O6, and it has a molecular weight of 442.32 g/mol. It is a deuterated form of Brimonidine Tartrate, which means it has four hydrogen atoms replaced with deuterium atoms.
Brimonidine-d4 D-Tartrate is a prescription medication and should only be used under the guidance of a healthcare professional. It is not recommended for use in children under the age of 2 years old, and caution should be exercised in patients with cardiovascular or cerebrovascular disease, depression, or Raynaud's phenomenon.
The most common side effects of Brimonidine-d4 D-Tartrate include ocular hyperemia, burning sensation, foreign body sensation, and blurred vision. Serious side effects are rare but can include allergic reactions, bradycardia, and hypotension.
In conclusion, Brimonidine-d4 D-Tartrate is an effective medication for treating glaucoma and ocular hypertension. It works by reducing intraocular pressure and increasing the outflow of aqueous humor. It is important to follow the dosage and administration instructions provided by a healthcare professional to ensure safe and effective use of this medication.
